InvestorsHub Logo
Followers 46
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: Doc logic post# 210199

Friday, 01/25/2019 3:24:43 PM

Friday, January 25, 2019 3:24:43 PM

Post# of 700256
Yes Doc.
I've no problems with the trial.
Though I'm sceptical about the likely success of Ipi in GBM.

But the blatant hype by the Evening Standard is reprehensible.

Patients with the same deadly brain tumour suffered by Tessa Jowell are starting to receive immunotherapy on the NHS for the first time.

A landmark trial has opened at the National Hospital for Neurology and Neurosurgery in Bloomsbury for people with glioblastoma.

Baroness Jowell, the former Olympics minister, had surgery there and campaigned for greater access to innovative therapies prior to her death last May.

The trial, described as the most important for brain cancer in 15 years, recruited the first of 120 patients last week. Drugs firm Bristol-Myers Squibb is donating £6 million worth of ipilimumab, while the National Brain Appeal is halfway towards raising £250,000 to cover the trial’s administration costs.



Exactly who describes it as the most important for brain cancer for 15 yrs?
What makes it a 'landmark trial'?
And as for patients receiving it on the NHS. That is just plain wrong.
Why are patients having to resort to online fundraising, if it is available on the NHS?

https://www.standard.co.uk/news/health/brain-tumour-patients-to-receive-immunotherapy-for-first-time-on-the-nhs-a4046331.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News